RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Impact of Diet Containing Grape Pomace on Growth Performance and Blood Lipid Profile of Young Rats

        Ivy Smith,Jianmei Yu,Steven L. Hurley,Tracy Hanner 한국식품영양과학회 2017 Journal of medicinal food Vol.20 No.6

        Grape pomace (GP), the residue of grapes after wine making, is rich in dietary polyphenols and fiber, and it has potential to serve as a functional food ingredient to improve health. However, high polyphenol diets have also been reported to inhibit the growth of young animals and cause liver necrosis. This study investigated the effect of diets containing different amounts of GP on the growth performance and blood lipid profile by using a young rat model. Twenty female Sprague–Dawley rats of age 7 weeks were randomly divided into four groups that were fed AIN-93G diets that were modified by substituting 0%, 10%, 20%, and 30% of carbohydrate with GP for 10 weeks (the diets, thus, obtained contained 0%, 6.9%, 13.8%, and 20.7% of GP). The group fed original AIN-93G (0% GP) was used as control. Feed consumption, body weight, length, and height were recorded weekly. Blood samples were taken biweekly to analyze plasma lipid profile. At the end of the feeding period, the rats were fasted overnight and euthanized by exsanguination under anesthesia. Livers, hearts, and kidneys were collected, and their weights were recorded. Results show that the diet containing a maximum of 20.7% of GP did not influence the body weights, lengths, and heights of rats. As the GP content increased, the blood triglyceride and very low-density lipoproteins (VLDL) decreased, the high-density lipoprotein (HDL) and low-density lipoprotein (LDL) increased slightly but were statistically significant, and total cholesterol remained constant. In conclusion, GP in the AIN-93G diet did not influence the growth performance of young rats, but it exhibited both positive and negative effects on the blood lipid profile.

      • SCIESCOPUS

        Analysis and performance of offshore platforms in hurricanes

        Kareem, Ahsan,Kijewski, Tracy,Smith, Charles E. Techno-Press 1999 Wind and Structures, An International Journal (WAS Vol.2 No.1

        Wind effects are critical considerations in the design of topside structures, overall structural systems, or both, depending on the water depth and type of offshore platform. The reliable design of these facilities for oil fields in regions of hostile environment can only be assured through better understanding of the environmental load effects and enhanced response prediction capabilities. This paper summarizes the analysis and performance of offshore platforms under extreme wind loads, including the quantification of wind load effects with focus on wind field characteristics, steady and unsteady loads, gust loading factors, application of wind tunnel tests, and the provisions of the American Petroleum Institute Recommended Practice 2A - Working Stress Design (API RP 2A-WSD) for the construction of offshore structures under the action of wind. A survey of the performance of platforms and satellite structures is provided, and failure mechanisms concerning different damage scenarios during Hurricane Andrew are examined. Guidelines and provisions for improving analysis and design of structures are addressed.

      • SCISCIESCOPUS

        Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

        Cegielski, J. Peter,Dalton, Tracy,Yagui, Martin,Wattanaamornkiet, Wanpen,Volchenkov, Grigory V.,Via, Laura E.,Van Der Walt, Martie,Tupasi, Thelma,Smith, Sarah E.,Odendaal, Ronel,Leimane, Vaira,Kvasnov Oxford University Press 2014 Clinical Infectious Diseases Vol.59 No.8

        <P>Nearly 15% of multidrug-resistant (MDR) tuberculosis cases developed resistance to the fluoroquinolones, the second-line injectable drugs, or both during treatment for MDR tuberculosis. The rate of acquired resistance was significantly lower in programs that met specific performance criteria.</P><P><B><I>Background.</I></B> Increasing access to drugs for the treatment of multidrug-resistant (MDR) tuberculosis is crucial but could lead to increasing resistance to these same drugs. In 2000, the international Green Light Committee (GLC) initiative began to increase access while attempting to prevent acquired resistance.</P><P><B><I>Methods.</I></B> To assess the GLC's impact, we followed adults with pulmonary MDR tuberculosis from the start to the end of treatment with monthly sputum cultures, drug susceptibility testing, and genotyping. We compared the frequency and predictors of acquired resistance to second-line drugs (SLDs) in 9 countries that volunteered to participate, 5 countries that met GLC criteria, and 4 countries that did not apply to the GLC.</P><P><B><I>Results.</I></B> In total, 832 subjects were enrolled. Of those without baseline resistance to specific SLDs, 68 (8.9%) acquired extensively drug-resistant (XDR) tuberculosis, 79 (11.2%) acquired fluoroquinolone (FQ) resistance, and 56 (7.8%) acquired resistance to second-line injectable drugs (SLIs). The relative risk (95% confidence interval [CI]) of acquired resistance was lower at GLC-approved sites: 0.27 (.16–.47) for XDR tuberculosis, 0.28 (.17–.45) for FQ, and 0.15 (.06–.39) to 0.60 (.34–1.05) for 3 different SLIs. The risk increased as the number of potentially effective drugs decreased. Controlling for baseline drug resistance and differences between sites, the odds ratios (95% CIs) were 0.21 (.07–.62) for acquired XDR tuberculosis and 0.23 (.09–.59) for acquired FQ resistance.</P><P><B><I>Conclusions.</I></B> Treatment of MDR tuberculosis involves substantial risk of acquired resistance to SLDs, increasing as baseline drug resistance increases. The risk was significantly lower in programs documented by the GLC to meet specific standards.</P>

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼